Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer Drops IP Suit Against MDS, Life Technologies

NEW YORK (GenomeWeb News) – PerkinElmer has withdrawn a patent infringement suit it filed last week against MDS, its MDS Analytical Technologies division, and Life Technologies, according to court documents.

Last week, PerkinElmer filed the suit in the US District Court for the District of Massachusetts, claiming that the MDS Analytical Technologies/Life Technologies joint venture is infringing five patents held by PerkinElmer through sales of the JV's QSTAR line of mass spectrometers.

PerkinElmer has not said why the suit has now been withdrawn, and company officials were unable to respond to a request for comment before this article was published. Officials from Life Technologies declined to comment.

Yesterday, MDS announced that it and PerkinElmer had reached a settlement in a separate legal battle in Canada. In that action, PerkinElmer had challenged MDS' pending sale of a joint venture between the firms to Danaher, which has inked a deal to acquire MDS Analytical Technologies.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.